Chief Executive Officer
CurrentLeading Persista Bio into large animal proof-of-concept and product development. Persista Bio™ O2Line™ is an oxygenated cell therapy sytem that sustains compact implants that free patients from immunosuppression. Initial indication is Type 1 Diabetes